Frequently Asked Questions
The market is segmented based on , By Dosage Forms (Oral Capsule, Oral Solution, Oral Tablet, Extended Release), Application (Epilepsy, Neuropathic Pain, Anxiety Disorder, Others), Drug Class (Fibromyalgia Agents, Anticonvulsants, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2031.
.
The Global Pregabalin Market size was valued at USD 824.75 USD Million in 2023.
The Global Pregabalin Market is projected to grow at a CAGR of 3.53% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Rest of Middle East and Africa, Brazil, Rest of South America.
